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Abstract
Background: Pluripotency and self-renewal of human embryonic stem cells (hESCs) is mediated by a complex interplay
between extra- and intracellular signaling pathways, which regulate the expression of pluripotency-specific transcription
factors. The homeodomain transcription factor NANOG plays a central role in maintaining hESC pluripotency, but the
precise role and regulation of NANOG are not well defined.
Methodology/Principal Findings: To facilitate the study of NANOG expression and regulation in viable hESC cultures, we
generated fluorescent NANOG reporter cell lines by gene targeting in hESCs. In these reporter lines, the fluorescent reporter
gene was co-expressed with endogenous NANOG and responded to experimental induction or repression of the NANOG
promoter with appropriate changes in expression levels. Furthermore, NANOG reporter lines facilitated the separation of
hESC populations based on NANOG expression levels and their subsequent characterization. Gene expression arrays on
isolated hESC subpopulations revealed genes with differential expression in NANOG
high and NANOG
low hESCs, providing
candidates for NANOG downstream targets hESCs.
Conclusion/Significance: The newly derived NANOG reporter hESC lines present novel tools to visualize NANOG expression
in viable hESCs. In future applications, these reporter lines can be used to elucidate the function and regulation of NANOG
in pluripotent hESCs.
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Introduction
Embryonic stem cells have the unique capability to replicate
indefinitely while maintaining pluripotency, i.e. the potential to
develop into all cell types of the adult organism. In human
embryonic stem cells (hESCs), external ligands like Activin A/
TGFb/Nodal, FGF2 and Insulin/IGF cooperate to activate
downstream transcription factors, thereby creating a complex
signaling network that ultimately maintains the pluripotent state.
One major component of the pluripotency signaling network is the
homeodomain transcription factor NANOG [1,2], which together
with OCT4 and SOX2 constitutes the core transcription factor
network in hESCs [3]. Experimental knockdown of NANOG
expression leads to hESC differentiation to embryonic and/or
extraembryonic lineages, depending on the experimental condi-
tions and on cell line-intrinsic determinants [4,5,6]. Conversely,
overexpression of NANOG in hESCs promotes self-renewal in the
absence of feeders [7] and eliminates the requirement for Activin
A in feeder-free systems [6,8]. Moreover, NANOG expression is
required to establish full pluripotency during reprogramming of
fibroblasts to induced pluripotent stem (iPS) cells, as well as for the
formation and stabilization of pluripotent epiblast and germ cells in
vivo [9,10,11]. Thus, it seems that NANOG expression serves both
as a determinant and an indicator for bona fide pluripotency,
albeit the exact role of NANOG in establishing and maintaining
pluripotency remains to be determined.
Reporter cell lines, in which a reporter gene is expressed from
a specific endogenous promoter, are valuable tools to study gene
regulation and function in real-time in living cells, which cannot
be achieved by conventional biochemical and immunological
methods. Reporter cell lines have been successfully applied in
embryonic stem cell research to identify inducers and repressors
of specific promoters (e.g. in high throughput screens with
chemical or RNAi libraries) and to separate subpopulations of
differentiated cells [12,13,14,15,16,17]. Thus, Nanog reporter
lines were created and applied to screen for signaling pathways
inducing mouse embryonic stem ce l l( m E S C )d i f f e r e n t i a t i o n
[18], to delineate the role of Nanog in pluripotency of mESCs
and during embryogenesis [9,19,20], and to monitor iPS cell
generation during reprogramming experiments [10,21]. How-
ever, pluripotency and differentiation is regulated through
different pathways in murine and human cells, which is reflected
by different marker expression and response to signaling
molecules of mESCs versus hESCs (reviewed in [22]). This
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hESCs.
To enable the study of NANOG expression and NANOG-
mediated pluripotency in hESCs, we derived NANOG reporter
cell lines by gene targeting in hESCs. We chose to pursue a gene
targeting strategy rather than random transgenic integration of the
reporter construct to avoid uncontrollable position effects on
reporter expression, and to enable the accurate expression of the
reporter gene from the endogenous regulatory sequences of the
NANOG locus. These novel NANOG reporter cell lines constitute
efficient tools to study the role and regulation of NANOG in
human pluripotent cells.
Materials and Methods
Human embryonic stem cell culture and differentiation
to embryoid bodies
The hESC lines HUES-1 and HUES-3 used in this study were
obtained from the Howard Hughes Medical Institute (Harvard
University, Cambridge, MA) and derived as previously described
[23]. HESCs were grown on mitomycin C-treated murine
embryonic fibroblast (MEF) feeders in medium containing KO-
DMEM, 20% knockout serum replacement, 10ng/ml bFGF, 1%
non-essential aminoacids, 1% Glutamax, 0,1% beta-Mercapto-
ethanol and 1% Penicillin/Streptomycin (all from GIBCO,
Invitrogen). Cells were passaged with 0,05% trypsin/EDTA
(GIBCO, Invitrogen) and re-plated at a split ratio of 1:3 to 1:6.
For feeder-free culture, hESCs were transferred to matrigel
(Becton Dickinson)-coated culture dishes and fed with mTeSR1
medium (Stem Cell Technologies). Cells were passaged with
dispase at a split ratio of 1:2 to 1:3.
For Activin A response experiments, cells were seeded in
matrigel-coated 24-well plates at a density of 100.000 cells/well in
mTeSR1 medium. Activin A was added to the medium 24 hours
after seeding of cells. Expression of eGFP was analyzed 48 hours
after addition of Actvin A by flow cytometry.
For embryoid body (EB) differentiation, cells were plated at a
density of one million cells/ml in Petri dishes and cultured with
hESC culture medium without bFGF or in embryoid body
medium containing 20% FBS as previously published [24].
Samples for flow cytometry and PCR were taken on days 0–28
of differentiation and analyzed as described below. For immuno-
fluorescence staining, EBs from day 22 (NANeG3 cells) or day 10
(NANeG1 cells) were plated on matrigel-coated glass cover slips
and incubated for additional 6–7 days with hESC medium or EB
medium.
Karyotyping of hESC clones was performed by standard G-
banding in collaboration with the Institute for Clinical Genetics at
the Universities of Lund, Sweden. For each analysis, 20–25
metaphases were evaluated.
BAC recombineering
All recombineering reagents including the recombineering-
competent Escherichia coli (E. coli) strain SW102 were obtained from
the Biological Resources Branch preclinical repository of the
National Cancer Institute (Maryland, USA). A detailed description
of materials is given on the website http://recombineering.ncifcrf.
gov. The bacterial artificial chromosome (BAC) CTD-2317D19
containing the human NANOG locus was obtained from Invitro-
gen. The identity of the BACs was verified by restriction enzyme
digestion and sequencing. The retrieval vector pBR322 was
obtained from New England Biolabs. All recombineering
experiments were performed according to protocols published
previously [25,26,27,28] and http://recombineering.ncifcrf.gov.
The eGFP-pSV40-Neo
R reporter cassette was obtained by
conventional restriction cloning. The rabbit beta globin intron 2
was cloned into the XhoI site of pEGFP-N1 (Clonetech). The
pSV40-Neo
R selection cassette was PCR-amplified from pEGFP-
N1 with chimeric primers containing loxP sites and recognition
sites for the restriction enzymes DraIII and BsaI (see supplemen-
tary Text S1 for primer sequences). The resulting PCR product
was digested and ligated into DraIII and BsaI sites of pEGFP-N1,
replacing the original pSV40-Neo
R cassette. The eGFP-pSV40-
Neo
R reporter cassette and the retrieval plasmid pBR322 were
amplified by PCR (Accuprime Pfx Polymerase, Invitrogen) prior to
recombineering. The primers used for these PCR reactions
contained 50bp of homology to the respective target sequence
within the BAC (see supplementary Text S1 for primer sequences).
The reporter cassette was inserted 59 to the start codon of the
NANOG gene into the BAC. For retrieval into pBR322,
recombineering target sites within the BAC lying 12.5kb upstream
and 3.5kb downstream of the reporter cassette were chosen. The
integrity of the finalized targeting constructs was verified by PCR,
restriction analysis and sequencing.
Gene targeting
The NANOG targeting vector was purified from E.coli (Genomed
Jetstar DNA preparation kit) and linearized with I-SceI. Five hours
before electroporation, medium on hESCs was changed and the
Rock-inhibitor Y-27632 (Calbiochem), which increases the
survival of hESCs after single-cell dissociation [29], was added at
a concentration of 10mM. Exponentially growing hESCs were
harvested with trypsin/EDTA, washed with phosphate buffered
saline (PBS) and counted. HESCs were resuspended in 700mlo f
ice-cold PBS containing 40mg of the targeting vector. Between four
and six million hESCs were used for each transfection.
Electroporation was performed in 0.4 cm cuvettes on a Gene
Pulser XCell (BioRad) with the parameters 250V, 500mFd or
800V, 10mFd. After electroporation, cells were washed once with
pre-warmed medium and plated on 10cm dishes containing
neomycin-resistant MEFs in the presence of Y-27632 (10mM).
Two to three days after transfection, selection with Geneticin
(Invitrogen) (100 mM) was started and maintained for 7–10 days.
Emerging clones with undifferentiated morphology were counted
and examined for eGFP expression. Clones expressing eGFP were
picked and plated in 24-well plates on MEFs in the presence of Y-
27632. When the clones reached sub-confluence, they were
detached by trypsin/EDTA treatment and expanded. PCR to
detect NANOG gene targeting over the 39 flanking region was
performed on genomic DNA of hESC clones using Elongase
(Invitrogen) and the cycle conditions 93uC/1min, 58uC/30sec,
68uC/7min (repeat 45 times). Gene targeting of the 59 flanking
region was detected using the Failsafe PCR system (Epicentre
Biotechnologies) and the cycle conditions 93uC/1min, 62uC/
30sec, 70uC/16min (repeat 30 times). Primer sequences are shown
in supplementary Text S1. The identity of the obtained PCR
products was verified by XhoI+SpaI digestion of the 59PCR
product and HindIII digestion of the 39PCR product.
Immunofluorescence
HESCs growing on tissue culture dishes or on matrigel-coated
glass cover slips were fixed with 4% paraformaldehyde/PBS for
15 minutes, permeabilized with 0,05% Triton-X-100/PBS for
20 minutes and pre-incubated with 5% skim milk/PBS for one
hour. Primary antibodies were added in 5% skim milk/PBS at the
following dilutions: NANOG (Sigma N3038) 1:300; Oct4 (Santa
Cruz sc-5279) 1:500; Tra-1-60 (Santa Cruz sc-21705) 1:250; Tra-
1-81 (Santa Cruz sc-21706) 1:250; SSEA-4 (Developmental studies
NANOG Reporters from Human ESC
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G7121) 1:1000; Sox1 (Abcam ab22572) 1:200; a-smooth muscle
actin (Sigma F3777) 1:200; a-fetoprotein (Sigma A8452) 1:400,
Albumin (Bethyl A80-129-F) 1:200. Incubation with primary
antibodies was performed over night at 4 degrees. Cells were
washed three times with PBS. Secondary antibodies were added
for 1h at room temperature in PBS at the following dilutions: anti-
mouse-Cy3 (Jackson Laboratories 715-165-150) 1:300–500; anti-
rabbit-Alexa 488 (Molecular Probes A11008) 1:500; anti-mouse-
Alexa 647 (Molecular probes A-31571) 1:500. Cells were washed
three times with PBS and mounted in the presence of DAPI
nucleic acid stain. Images were taken using an Axioplan 2
Fluorescence microscope and Axiovision software.
Semi-quantitative and quantitative polymerase chain
reaction
Total RNA was isolated from hESCs or embryoid bodies using
the Genelute total RNA kit (Sigma). RNA was digested with
DNAseI (Invitrogen) and reverse transcribed to cDNA using
Superscript III reverse transcriptase (Invitrogen). Semi-quantita-
tive PCR was performed with Taq-polymerase (Sigma). Primers,
cycle numbers and annealing temperatures for semi-quantitative
PCR are listed in supplementary Text S1. PCR products were
separated on agarose gels in presence of ethidium bromide and
analyzed under UV light. For quantitative real-time PCR,
reactions were performed with Platinum quantitative PCR
SuperMix (Invitrogen Cat.no. 11743) in the presence of SYBR
green (Invitrogen). PCR cycles on a 7900HT fast real time PCR
system (Applied Biosystems) were performed as follows: 50uC/
2min, 95uC/2min, 95uC/15sec, 60uC/25sec, 73uC/30sec (steps
3–5 were repeated 40 times). Gene expression levels were
normalized to endogenous GAPDH expression and quantified
using the DDCt method [30]. Primers used for quantitative real-
time PCR are listed in supplementary Text S1.
Copy-number determination by quantitative PCR
The copy number of the NANOG targeting vector in NANeG
cells was determined by quantitative PCR following the
guidelines for assay design, controls and evaluation given in
[31]. A fragment of the NANOG proximal promoter (2758 to
2858) was amplified and quantified relative to the copy number
of the single-copy reference genes GDF3 (GeneID: 9573) and
FOXJ2 (GeneID: 55810). Primers used for qPCR reactions are
shown in supplementary Text S1. PCR cycles on a 7900HT fast
real time PCR system (Applied Biosystems) or a Step1Plus real
time PCR system (Applied Biosystems) were performed as follows:
50uC/2min, 95uC/2min, 95uC/15sec, 60uC/25sec, 73uC/30sec
(steps 3–5 were repeated 40 times). Measurements on all samples
were repeated in at least three qPCR experiments which were
performed in triplicates. A standard curve with serial dilutions of
hESC genomic DNA ranging from 0.78 to 25ng/reaction in 2-
fold dilution steps was prepared by plotting mean threshold cycle
(Ct) values against log-transformed gDNA concentrations. A
linear trend line was fitted into each standard curve and slopes (y)
and correlation coefficients (R
2) were obtained in Microsoft
Excel. Assay efficiencies were calculated using the formula
E=10
(21/y). Melt curve analysis and absence of amplification
products from water controls confirmed the specificity of the
assays. Copy numbers of the NANOG promoter fragment
(pNANOG) in test samples were normalized to reference assays
(GDF3 or FOXJ2) and compared to untransfected hESCs
(control) using the amplification efficiency-adjusted DDCt method
with the formula:
RatiopNANOG~ EpNANOG
 DCtNANOG control-test sample ðÞ =
Eref assay
 DCtref assay control-test sample ðÞ
[32].
Statistical significance of different pNANOG quantities between
samples was analysed with student’s t-test.
Flow cytometry and cell sorting
For quantification of eGFP expression, hESCs growing in
feeder-free culture or embryoid bodies were dissociated with
Trypsin/EDTA and resuspended in PBS. Expression of eGFP was
measured on a FACSCalibur flow cytometer (Becton Dickinson)
using CellQuest software. Ten thousand living cells were counted
and analyzed for eGFP expression, using untransfected hESCs as
negative controls. For cell sorting, NANeG cells were dissociated
with trypsin/EDTA and resuspended in PBS containing 2% fetal
bovine serum and the Rock-inhibitor Y-27632 (10mM). Cell
sorting of eGFP
high and eGFP
low hESCs was performed on a DiVa
flow cytometer with DiVa software (Becton Dickinson). Approx-
imately 200.000 cells were sorted from each subpopulation and
used for mRNA extraction. Re-analysis after cell sorting confirmed
that the purity of the sorted populations was .95%.
Gene expression arrays
Gene expression arrays were performed with TaqMan Human
Stem Cell Pluripotency Array plates (Applied Biosystems #
4414077) according to the manufacturer’s instructions. Briefly,
cDNA from FACS-sorted NANeG subpopulations was combined
with gene expression mastermix (Applied Biosystems #4369016)
and loaded onto array plates containing gene-specific primers and
probes. Gene expression was measured on a 7900HT fast real time
PCR system (Applied Biosystems) with the cycle conditions 50uC/
2min, 95uC/10min, 95uC/15sec, 60uC/1min (steps 3–4 were
repeated 40 times). Gene expression levels were normalized to the
threshold cycle (Ct) values of endogenous GAPDH and quantified
using the DDCt method [30].
Results
Gene targeting of the NANOG locus in hESCs
The NANOG targeting vector used for this study (Fig. 1A) was
created by bacterial artificial chromosome (BAC) recombineering
(i.e. BAC engineering by homologous recombination) [33]. BAC
recombineering is a fast and efficient method to create gene
targeting vectors containing .10kb of homologous DNA, which is
required for optimal gene targeting efficiency [34]. A BAC
containing the human NANOG gene plus .10 kb of flanking
sequences was identified using the genome browser at http://
genome.ucsc.edu. A reporter cassette, consisting of an enhanced
green fluorescent protein (eGFP) gene and a neomycin resistance
gene was inserted into the BAC immediately upstream of the
NANOG start codon. The finalized targeting vector, containing
homology arms of 12.5kb and 3.5kb, was retrieved into a bacterial
plasmid through a second round of recombineering.
The hESC lines HUES-1 and HUES-3 were transfected with
the pNANOG
eGFP vector by electroporation. Clones arising from
transfections were scored for eGFP expression and eGFP positive
clones were isolated and expanded. Gene targeting of the NANOG
locus was assessed by PCR amplification of the 39 region flanking
the reporter cassette. A PCR product of 5.1kb size was amplified
from genomic DNA of NANOG gene targeted clones as shown in
Figure 1B. The identity of the PCR product was verified by
NANOG Reporters from Human ESC
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12533Figure 1. Gene targeting of NANOG in hESCs and expression of the eGFP reporter. The strategy for gene targeting of the NANOG locus is
presented schematically in A. The NANOG targeting vector was inserted into the 59 untranslated region of the NANOG gene upstream of the NANOG
start codon (ATG), resulting in an eGFP-tagged NANOG allele. Primer binding sites for PCR-based screening are indicated as arrows (A, lower panel).
Red coloring marks targeting vector–derived NANOG sequences which replace endogenous NANOG sequences upon gene targeting. Abbreviations:
bGl, rabbit beta-globin Intron 2; eGFP, enhanced green fluorescent protein gene; LP, locus of X-over P1 (recognition site for Cre-recombinase); Neo
R,
neomycin resistance gene; pA, polyadenylation site; Ex, exon; Ex19, Ex29, tuncated exon 1, 2. B) PCR experiments to screen for NANOG gene targeting
events. A representative PCR screen of 39 targeting events is shown in B, upper panel for three individual clones (lane 1 and 3: clones positive for 39
NANOG Reporters from Human ESC
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shown). The results of gene targeting experiments are summarized
in Table 1. Clones with a targeted NANOG allele (designated
NANeG) were obtained from both HUES cell lines. The relative
targeting frequency was significantly higher in HUES-3 (11.4% of
drug-resistant clones) than in HUES-1 (0.6% of drug-resistant
clones). To test if additional copies of the targeting vector have
been incorporated in the genome of NANeG cells by random
insertion, a quantitative PCR assays to detect a fragment of the
NANOG proximal promoter (pNANOG) in genomic DNA of
hESCs was established. In addition, quantitative PCR assays for
two single-copy reference genes (GDF3 and FOXJ2) were
established to measure relative quantities of pNANOG in
untransfected hESCs and in NANeG clones obtained from
transfections with the NANOG targeting vector. Preparation of
standard curves with hESC genomic DNA revealed amplification
efficiencies between 90 and 100% and R
2 values of 0.99 for all
assays (Fig. S3A), showing that the assays fulfilled the quality
requirements for copy number determination on genomic DNA
[31]. Relative quantities of pNANOG were determined for four
NANeG clones (NANeG1, 3, 11 and 31) and three clones which
showed eGFP fluorescence but were negative for gene targeting
(Transgenic clones 12, 13 and 32) (Fig. S3B). As expected, all
transgenic clones contained significantly increased quantities of
pNANOG sequences in genomic DNA samples (p,0.01 for
pNANOG vs. GDF3 and p,0.05 for pNANOG vs. FOXJ2).
NANeG clones 1, 3 and 31 showed no significant increase of
pNANOG sequences above control hESCs (p.0.1) in both assays,
whereas NANeG11 contained significantly elevated pNANOG
levels in genomic DNA samples (p,0.01 in both assays). These
results indicate that NANeG1, 3 and 31 contain a single copy of
the NANOG targeting vector integrated into the endogenous
NANOG locus by gene targeting, whereas NANeG11 contains
additional copies of the targeting vector.
Karyotype analysis on a subset of gene targeted clones was
performed in passage 6–7. Both cell lines gave rise to clones with
normal karyotype, but chromosomal aberrations (frequently
involving gain of chromosomes 12, 17 or 20) were also observed
in a subset of clones derived from both cell lines. The clones
NANeG1 (derived from HUES-1) and NANeG3 (derived from
HUES-3) showed a normal diploid karyotype and were chosen for
further analysis. Correct gene targeting of the 59region flanking the
reporter cassette was confirmed by long-range PCR (Fig. 1B) and
the identity of the 13.3kb PCR fragment was further verified by
restriction enzyme digestion (Fig. 1C).
Both NANeG lines expressed the hESC markers OCT4, SSEA-
4, TRA-1-60 and TRA-1-81 (Fig. S1A and S2A). Pluripotency of
both lines was tested by embryoid body differentiation, where they
gave rise to cell types representative of the three embryonic germ
layers (Fig. S1B, C and S2B, C).
Characterization of reporter gene expression following
NANOG gene targeting
NANeG cells grew in compact colonies in a feeder-free culture
system (Fig. 1D) and expressed eGFP in most cells within the
undifferentiated colonies. In areas of spontaneous differentiation,
eGFP expression was downregulated. Similar to Nanog-eGFP
mESCs [9,20], NANeG cells expressed the eGFP reporter in a
graded fashion, with subpopulations of cells expressing high, low
or no eGFP at a given timepoint (Fig. 1C). Thereby, mean eGFP
intensities were of up to 100-fold higher than auto-fluorescence
levels measured in the negative control. The relative distribution
eGFP high, low and negative cells varied between cell lines,
passages and culture conditions (data not shown), most likely due
to variable levels of spontaneous differentiation within the cultures.
Immunostaining for NANOG revealed extensive co-expression
of NANOG and eGFP in undifferentiated NANeG cells growing
on murine fibroblast feeders (Fig. 2A) and in feeder-free culture
(Fig. 2B). In areas of spontaneous differentiation (arrows in
Fig. 2B), both NANOG and eGFP expression were downregulat-
ed. In both NANeG lines, a subset of cells stained positive for
NANOG but express low levels or no eGFP. The same
observation was made in sub-clones of NANeG3 created by
single-cell deposition of eGFP-positive cells in 96-well plates (data
not shown), indicating that this discrepancy was not due to the
presence of contaminating wild-type hESCs within the NANeG
lines.
To test the adequate responsiveness of the eGFP reporter,
NANeG cells were exposed to culture conditions that modulate
NANOG expression in hESCs. Differentiation to embryoid bodies
led to the rapid downregulation of eGFP (Fig. 3A, B) in both cell
lines. Thereby, downregulation of eGFP expression followed
downregulation of endogenous NANOG expression in response to
hESC differentiation (Fig. 3C). Conversely, NANOG expression in
hESCs can be activated by Activin A [6,8]. We therefore tested the
Table 1. Gene targeting of the NANOG locus in hESCs.
HUES-1 HUES-3
Transfected cells 19 Million 9 Million
G418
R clones 637 167
G418
RGFP
+ clones 33 40
Targeted clones 4 19
Absolute targeting efficiency
a 2,1E-7 2,1E-6
Relative targeting efficiency
b 0,6% 11,4%
aTargeted clones divided by number of transfected cells.
bPercentage of targeted clones among G418
R clones.
doi:10.1371/journal.pone.0012533.t001
gene targeting; lane 2: clone negative for 39 gene targeting) with Neo/F and Ex3/R primers (fragment size 5,1kb). The NANOG
eGFP BAC containing the
reporter cassette integrated into the NANOG locus was used as positive control (BAC). m, DNA size marker. Correct targeting of the 59 flanking region
was tested by long-range PCR as shown in B, lower panel. PCR products of 13.3 kb were obtained with 59/F and bGL/R primers with genomic DNA
from NANeG1 and NANeG3 clones (lane 1, 2) and with the NANOG
eGFP BAC template as positive control. C) The identity of the PCR products was
verified by restriction enzyme digestion of the 39PCR product with Hind III (upper panel) and SpeI/XhoI digestion of the 59PCR product (lower panel).
Expected fragments for 39PCR products were 269bp, 965bp, 1.7kb and 2.2kb (marked by stars). Expected fragments for 59PCR products were 374bp,
470bp, 1.7kb and 10.9kb (marked by stars). The 374bp and 470bp fragments are shown with higher magnification and contrast in the insert in C
lower panel. Lanes contain PCR-products obtained with NANOG
eGFP BAC (BAC), NANeG1 (1), NANeG3 (2), DNA size marker (m). XhoI (X) SpeI (S) and
HindIII (H) sites within the gene targeted NANOG locus are indicated in A, lower panel. D) Histogram of eGFP expression levels in NANeG3 cells
measured by flow cytometry. Wild-type HUES-3 cells were used as negative control. E) Brightfield (upper panel) and corresponding epifluorescence
(middle) and merged (lower panel) images of NANeG1 and NANeG3 in a feeder-free culture system. Dashed lines indicate areas of spontaneous
differentiation with loss of eGFP expression. Scale bar: 100mm.
doi:10.1371/journal.pone.0012533.g001
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in Figure 3D and E, Activin A caused a dose-dependent increase
of eGFP expression up to a concentration of 50ng/ml, confirming
the responsiveness of the eGFP reporter to exogenous signals that
activate NANOG expression in hESCs.
Gene expression profiling of hESC subpopulations with
different NANOG expression levels
Reporter cell lines enable the fractioning of hESC populations
based on endogenous gene expression. In embryonic stem cells,
subpopulations with varying levels of Nanog expression co-exist and
have been isolated and characterized in the murine system [9,20],
but not from hESCs due to the lack of suitable reporter lines. To
study the heterogeneity of hESCs as a function of NANOG
expression, NANeG cultures were fractioned into eGFP
high and
eGFP
low subpopulations by flow cytometry (Fig. S4). NANOG
expression in the eGFP
low fraction was reduced to approximately 30
percent of expression levels in the eGFP
high fraction (Table 2). Since
NANOG is an important mediator of hESC self-renewal, we
analyzed the expression profile of 96 genes involved in hESC self-
renewal or differentiation in the isolated hESC fractions. Gene
expression patterns of stem cell markers and early differentiation
markers in NANeG lines largely resembled the expression pattern
detected inparentalHUESlines[35].Furthermore,severalmarkers
for neural (TH, SYP, NEUROD), hepatic (TAT), pancreatic (GCG,
INS, PDX1, PTF1a), blood (HBB, HBZ), and muscle lineages (MYF5,
MYOD) were low or absent in NANeG cultures.
Of those genes expressed in NANeG cells (Tables 2 and S1),
45% were differentially expressed (up- or downregulated $2-fold
in both cell lines) between NANOG
high and NANOG
low cells
(Table 2). Twenty-one genes were upregulated in NANOG
high
cells, most of which were classified as stem cell markers [35].
Interestingly, the mesoderm/primitive streak markers T, EOMES
and MIXl1 were also upregulated in NANOG
high cells compared
to NANOG
low cells. Amongst the 11 genes commonly downreg-
ulated in NANOG
high cells were the extracellular matrix-encoding
genes COL1A1, COL2A1, FN1 and LAMA1, as well as CDX2,
ACTC1 and PAX6, which mark trophoblast, cardiac and neural
differentiation, respectively. Several genes regulating cell adhesion
were differentially expression in the sorted populations: CDH1/E-
cadherin, PODXL and CD9 were upregulated in NANOG
high
cells whereas CDH5/VE-cadherin and CD34 were downregulat-
ed in NANOG
high cells. CDH2/N-cadherin was not differentially
expressed between NANOG
high and NANOG
low cells. Finally,
components of the transforming growth factor beta signaling
pathway were amongst those genes with the strongest difference in
expression levels between NANOG
high and NANOG
low cells.
Thus, NODAL, LEFTY1, TDGF1 and GDF3 were strongly
upregulated in NANOG
high cells while NOGGIN showed a
prominent downregulation in NANOG
high cells.
Figure 2. Co-expression of NANOG and eGFP in NANeG lines. Immunofluorescence staining of endogenous NANOG expression and co-
localization with eGFP in NANeG lines growing on murine feeders (A) or in feeder-free culture (B). Arrows indicate areas of spontaneous
differentiation with concomitant NANOG and eGFP downregulation. Scale bar: 100mm.
doi:10.1371/journal.pone.0012533.g002
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PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12533Figure 3. Modulation of reporter expression in NANeG lines. A) Brightfield and corresponding epifluorescence images of NANeG1
undergoing differentiation as embryoid bodies are shown for day 2, 4 and 9 of differentiation. Scale bar: 100mm. Downregulation of eGFP expression
during embryoid body differentiation was quantified by flow cytometry (B) and quantitative real-time PCR (C) in NANeG1 (upper panel) and NANeG3
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NANOG is an essential mediator of pluripotency in mammalian
embryos and in cultured pluripotent stem cells [6,7,9] and is
required to induce full pluripotency during reprogramming or cell
fusion experiments [10,11]. This makes NANOG an interesting
candidate gene to study the biological mechanism of pluripotency
in vitro. The detection of NANOG expression in hESCs has
depended on methods which require fixation and processing of
cells, which is labor-intensive and prevents the detection of
NANOG expression in real-time in viable cultures. To address
this, we describe here gene targeting of the NANOG locus in hESCs
to obtain fluorescent NANOG reporter cell lines. NANOG gene
targeting was performed with a BAC-derived targeting vector and
yielded comparable efficiencies to previous reports on gene
targeting in hESCs [36,37,38,39,40]. NANeG reporter cell lines
Table 2. Genes differentially expressed ($2-fold up/down-regulated in both cell lines) in NANOG
high and NANOG
low hESCs.
Expression NANOG
low/NANOG
high
Gene symbol Cellular process
a NANeG1 NANeG3 Assay
b
NODAL
c TGFb signaling pathway 0,06 0,16 T, Q
LEFTY1
d TGFb signaling pathway 0,11 0,14 T
CDH1
d Cell adhesion 0,10 0,20 Q
TDGF1
d TGFb signaling pathway 0,09 0,27 T, Q
POU5F1
d Transcription factor 0,10 0,30 Q
GFAP Intermediate filament 0,18 0,23 T
GAL Messenger neuropeptide 0,14 0,27 T
UTF1 Transcription factor 0,15 0,34 T
CD9 Cell adhesion 0,19 0,31 T
IFITM1 Transmembrane protein 0,16 0,39 T
T
c Transcription factor 0,18 0,43 T, Q
GDF3
c TGFb signaling pathway 0,20 0,43 T, Q
NANOG
d Transcription factor 0,36 0,29 T, Q
PODXL
c Cell adhesion 0,30 0,37 T
GABRB3 GABA receptor 0,39 0,29 T
EOMES
d Transcription factor 0,26 0,43 T, Q
FLT1 Receptor tyrosine kinase 0,31 0,39 T
MIXL1 Transcription factor 0,30 0,40 Q
GRB7 Growth factor receptor adapter 0,30 0,49 T
ZFP42
c Transcription factor 0,30 0,50 T, Q
DNMT3B DNA methylation 0,45 0,47 T
COL1A1 Extracellular matrix 3,12 2,37 T
LAMA1 Extracellular matrix 3,69 2,33 T
ACTC1 Cytoskeleton 3,03 3,04 T
COMMD3
d Protein binding 3,82 2,88 T
FN1 Extracellular matrix 3,96 3,35 T
CDH5 Cell adhesion 6,25 2,82 T
CD34 Cell adhesion 7,79 2,85 T
PAX6
d Transcription factor 2,32 8,64 T
NOG TGFb signaling pathway 8,18 5,76 T, Q
CDX2
d Transcription factor 2,60 12,80 Q
COL2A1 Extracellular matrix 20,51 227,51 T
aNCBI Entrez Gene Information.
bT: ABI TaqMan Stem Cell Pluripotency Array; Q: qPCR assay, primers listed in supplementary Text S1.
cPromoter bound by NANOG but not OCT4/SOX2 in hESC [3].
dPromoter bound by NANOG and OCT4/SOX2 in hESCs [3].
doi:10.1371/journal.pone.0012533.t002
(lower panel). D, E) NANeG cells growing in feeder-free culture were exposed to 0, 10, 50 or 100ng/ml Activin A (AA). Activin A induced eGFP
expression in a dose-dependent manner, as shown by flow cytometry (D). Mean fluorescence intensities of the eGFP+ population (indicated in D) in
NANeG3 (upper panel) and NANeG1 (lower panel) are shown in (E). For comparison, NANeG1 cells were grown on murine embryonic fibroblast
feeders (MEF) without addition of Activin A.
doi:10.1371/journal.pone.0012533.g003
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expression and multilineage differentiation in embryoid bodies.
The eGFP reporter gene showed a graded expression pattern in
undifferentiated cultures and was low or absent in a subset of
hESCs, as previously reported for mESC Nanog reporter lines
[9,20]. Co-expression of NANOG and eGFP protein was detected
in hESCs in undifferentiated cultures, but was coordinately lost in
areas of spontaneous differentiation. However, a subset of hESCs
stained positive for NANOG but showed no expression of eGFP.
This discrepancy was also observed in mESC lines targeted at the
Nanog locus [20] and could be due to different stability of
NANOG and eGFP mRNA and/or protein. Alternatively, the
eGFP-reporter containing allele may be selectively silenced in
NANeG cells by yet unidentified mechanisms. Reporter gene
expression was responsive to cell culture conditions which induce
or repress NANOG expression in vitro. Thus, NANOG and eGFP
were concomitantly downregulated during hESC differentiation,
whereas the addition of Activin A, which directly activates the
NANOG promoter in hESCs via its downstream effectors SMAD2
and SMAD3 [6,8], increased reporter gene expression.
Embryonic stem cells are a heterogeneous cell population,
consisting of subpopulations with variant expression levels of
pluripotency-associated markers and differentiation status [41].
Thus, murine ESCs show a heterogenous pattern of Nanog
expression, and Nanog
high and Nanog
low subpopulations are
characterized by differential gene expression [19]. Similar to
mESCs, hESCs show a heterogeneous expression pattern of
NANOG in undifferentiated cells [42]. The generation of
fluorescent NANOG reporter lines facilitated the isolation and
characterization of hESC subpopulations with distinct NANOG
expression levels. Gene expression analysis of 96 genes involved in
stem cell pluripotency or differentiation was carried out to identify
distinct gene expression patterns in NANOG
high and NANOG
low
subpopulations. Expectedly, we detected higher expression levels
of genes associated with hESC pluripotency (including NANOG
itself) in NANOG
high versus NANOG
low hESCs. Conversely,
differentiation markers for embryonic and extraembryonic tissues
(ACTC1, PAX6, CDH5, CDX2, CD34) and extracellular matrix
proteins (COL2A1, COL1A1, LAMA1, FN1) were upregulated in
NANOG
low hESCs. A similar upregulation of extracellular matrix
genes has been found in Nanog
low cell isolated from mESCs [19].
The primitive endoderm markers GATA4 and GATA6, which
were upregulated in Nanog
low mESCs [19] were upregulated in
NANOG
low cells of NANeG1 but slightly downregulated in
NANOG
low cells of NANeG3. Interestingly, genes involved in
primitive streak formation and mesoderm differentiation (NODAL,
T, EOMES, MIXL1) were upregulated in the NANOG
high fraction.
This observation is consistent with high Nanog expression levels in
the area of primitive streak formation in the mouse embryo, where
Nanog expression co-localized with the primitive streak marker
Mixl1 [42,43].
Promoter binding of NANOG has previously been studied on
18.000 annotated genes in hESCs [3]. Thereby, it was found that
NANOG binds to over 1600 promoters of both active and inactive
genes in hESCs, and that the majority of promoters bound by
NANOG were co-occupied by OCT4 and SOX2. When
comparing the list of genes differentially expressed in NANOG
high
and NANOG
low cells with the published promoter binding data,
we found that 14 out of 32 gene promoters (44%) were bound by
NANOG, indicating that they are direct transcriptional targets of
NANOG. Moreover, five genes differentially expressed in
NANOG
high and NANOG
low cells (NODAL, T, GDF3, PODXL
and ZFP42) were bound by NANOG but not OCT4 and SOX2,
indicating that NANOG plays a unique role in regulating
expression of these genes. In contrast, of those genes not
differentially expressed between NANOG
high and NANOG
low
cells, 12 out of 39 (31%) were co-occupied by NANOG, OCT4
and/or SOX2, but none was bound by NANOG only.
Previous knockdown studies performed to study the role of
NANOG in hESCs yielded variable results with respect to changes
in downstream gene expression, probably reflecting differences in
culture system and experimental design between those studies
[4,5,6,44]. In contrast, NANeG lines provide a novel system to
study spontaneous fluctuations in NANOG expression levels
within hESC cultures and concomitant changes in gene expression
patterns, which may lead to the identification of NANOG target
genes under steady-state hESC culture conditions.
In conclusion, we successfully derived fluorescent NANOG
reporter lines by gene targeting in hESCs. Reporter gene
expression responded to stimuli that modulate NANOG expres-
sion with appropriate changes in expression levels. Future
applications of NANeG lines include the identification of novel
regulators of NANOG expression and hESC pluripotency (e.g. in
high throughput screens with chemical, cDNA or shRNA libraries)
and the separation and extensive characterization of hESC
subpopulations with distinct NANOG expression levels to clarify
the role of NANOG in hESC pluripotency and differentiation.
Supporting Information
Figure S1 Expression of markers for pluripotency and differen-
tiation in NANeG1. A) Undifferentiated NANeG1 cells growing
on murine feeders were stained for OCT4, SSEA-4, TRA-1-60
and TRA-1-81 as indicated. Scale bar: 100mm. B) NANeG1 cells
were differentiated to embryoid bodies and subsequently plated on
matrigel-coated culture dishes. Differentiation to the three
embryonic germ layers was assessed by staining for beta-3-tublin
(TUBB3, ectoderm), alpha-fetoprotein (AFP, endoderm), albumin
(ALB, endoderm) and alpha-smooth-muscle actin (alpha-SMA,
mesoderm). Scale bar: 100mm. C) Semi-quantitative reverse
transcriptase polymerase chain reaction was used to detect
expression of germ-layer-specific markers in NANeG1 cells
differentiated to embryoid bodies. Samples were taken at the
indicated timepoints (day 0 to day 18) and tested for expression of
the ectodermal markers SOX1 and neurofilament (NFM), the
mesodermal markers T and CD31, the endodermal markers
alpha-fetoprotein (AFP) and albumin (ALB) and the trophecto-
dermal marker CDX2. Amplification of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) cDNA was used as internal
control.
Found at: doi:10.1371/journal.pone.0012533.s001 (2.81 MB TIF)
Figure S2 Expression of markers for pluripotency and differen-
tiation in NANeG3. A) Undifferentiated NANeG3 cells growing
on murine feeders were stained for OCT4, SSEA-4, TRA-1-60
and TRA-1-81 as indicated. Scale bar: 100mm. B) NANeG3 cells
were differentiated to embryoid bodies and subsequently plated on
matrigel-coated culture dishes. Differentiation to the three
embryonic germ layers was assessed by staining for beta-3-tublin
(TUBB3, ectoderm), SOX1 (ectoderm), alpha-fetoprotein (AFP,
endoderm) and alpha-smooth-muscle actin (alpha-SMA, meso-
derm). Scale bar: 100mm. C) Semi-quantitative reverse transcrip-
tase polymerase chain reaction was used to detect expression of
germ-layer-specific markers in NANeG3 cells differentiated to
embryoid bodies. Samples were taken at the indicated timepoints
(day 0 to day 28) and tested for expression of the ectodermal
markers SOX1 and PAX6, the mesodermal markers T, cardiac
troponin T (cTNT) and CD31, the endodermal markers alpha-
fetoprotein (AFP), SOX17 and albumin (ALB) and the trophecto-
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was used as internal control.
Found at: doi:10.1371/journal.pone.0012533.s002 (3.22 MB TIF)
Figure S3 Copy number of integrated targeting vector in
NANeG cells. A) Relative quantities of the NANOG proximal
promoter (pNANOG) and the single-copy genes GDF3 and
FOXJ2 were measured on a dilution series of genomic DNA from
wildtype hESCs. Threshold cycle (Ct) values from three indepen-
dent experiments were plotted against log-transformed concentra-
tions of genomic DNA. Trend lines were inserted and used to
obtain values for slope (y) and correlation coefficients (R2). B)
Quantities of pNANOG relative to GDF3 (upper panel) and
FOXJ2 (lower panel) were determined for three wildtype hESC
lines (HUES-3, HUES-1 and H9, grey bars), four NANeG clones
(clones 1, 3, 31 and 11, white bars) and three clones with random
transgenic insertion of the NANOG targeting vector (clones 12, 13
and 32, black bars). Plots show average and standard deviations
obtained from at least three independent experiments. The mean
of pNANOG vs.GDF3 and pNANOG vs. FOXJ2 in the three
wildtype hESC lines is included in both figures (striped bar) and
was used for statistical analyses to identify samples with
significantly increased amounts of pNANOG.
Found at: doi:10.1371/journal.pone.0012533.s003 (0.06 MB
PDF)
Figure S4 Isolation of eGFPhigh and eGFPlow populations
from NANeG cells. A) Flow cytometry profiles of NANeG1 and
NANeG3 during cell sorting. Gates for eGFPhigh and eGFPlow
cells are indicated. B) Expression of eGFP in eGFPlow cells
relative to eGFPhigh cells isolated from NANeG lines was
measured by quantitative PCR.
Found at: doi:10.1371/journal.pone.0012533.s004 (0.06 MB
PDF)
Text S1
Found at: doi:10.1371/journal.pone.0012533.s005 (0.08 MB
DOC)
Table S1 Genes not differentially expressed (less than 2-fold up/
downregulated in one or both cell lines) in NANOGhigh and
NANOGlow hESCs.
Found at: doi:10.1371/journal.pone.0012533.s006 (0.02 MB
XLS)
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